The purpose of HTA is to provide high-quality information to decision makers about the clinical effectiveness, cost-effectiveness, and broader impact of drugs, medical technologies, and health systems.
From diagnosis to treatment and in terms of medicines manufactured, healthcare biotechnology is a
Some 20-30 million Europeans are affected by rare diseases.
Biotechnology aims to target the causes of diseases rather than just the symptoms.
Biotechnology provides powerful tools to develop diagnostics and treatments for orphan diseases.
Biotechnology medicines and therapies use proteins, enzymes, antibodies and other substances natu